SS
MRVI icon

Simplicity Solutions’s Maravai LifeSciences MRVI Stock Holding History

Simplicity Solutions’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$156K Buy
23,760
+10,796
+83% +$69.7K ﹤0.01% 987
2023
Q3 		$130K Buy
+12,964
New +$142K ﹤0.01% 926

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Simplicity Solutions's MRVI Position: Q4 2023 in Review

Simplicity Solutions increased its Maravai LifeSciences (MRVI) stake by 83% in Q4 2023, buying an estimated $69.7K and bringing the position to 23,760 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #987.

Simplicity Solutions first reported a position in MRVI in Q3 2023 and has held it in 2 quarters since. 223 funds tracked by Wall St. Rank hold MRVI as of Q4 2023.

  • Simplicity Solutions held 23,760 shares of Maravai LifeSciences worth $156K as of Q4 2023.
  • Simplicity Solutions bought 10,796 Maravai LifeSciences shares in Q4 2023, an estimated $69.7K.
  • Maravai LifeSciences made up ﹤0.01% of Simplicity Solutions's portfolio in Q4 2023, its #987 holding.
  • Simplicity Solutions first reported a position in Maravai LifeSciences in Q3 2023 and has held it in 2 quarters since.
  • 223 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.